← Back to Search

Behavioral Intervention for HIV/AIDS Prevention in Black MSM

N/A
Recruiting
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Identifies as biologically male
Minimally 18 years and 0 months of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 36 months
Awards & highlights

Study Summary

This trial will test a behavioral intervention to promote HIV testing, education, support, and referral for pre-exposure prophylaxis in young black men who have sex with men in order to address the HIV crisis in Alabama.

Who is the study for?
This trial is for Black young men (18-29 years old) in Alabama who have sex with other men, can speak and read English, are sexually active, and either conduct or oversee community outreach and HIV testing. They must be willing to give informed consent.Check my eligibility
What is being tested?
The study is testing a behavioral intervention called Adapted Brothers Saving Brothers (aBSB), compared to standard street outreach methods. The goal is to increase HIV rapid testing, provide prevention education, support services, and refer eligible individuals for PrEP.See study design
What are the potential side effects?
Since this trial focuses on a behavioral intervention rather than medication, there may not be direct physical side effects. However, participants might experience stress or discomfort discussing personal behaviors related to HIV prevention.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am biologically male.
Select...
I am at least 18 years old.
Select...
I am between 18 and 29 years old.
Select...
I am a man who has sex with men.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~36 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 36 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability as assessed by participant self-rated satisfaction with the intervention
Did the study participant accept a community-based rapid HIV test after the delivery of the aBSB or standard outreach intervention?
Secondary outcome measures
Did the study participant secure a prescription for PrEP?

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: aBSBExperimental Treatment1 Intervention
aBSB is the adaptation of BSB. BSB a two part intervention to improve rates of community-based HIV testing and prevention education in black young MSM (YMSM). BSB was developed on Information Motivation Behavioral Skills (IMB) theory. The first part of BSB uses Motivational Interviewing in a culturally appropriate way to encourage participants to accept testing and return for test results. The second part is conducted after the participant has received his result, assuming it was not reactive and offers prevention education.
Group II: Street OutreachActive Control1 Intervention
Standard street outreach was used as the control in the original BSB trial.

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,573 Previous Clinical Trials
2,273,112 Total Patients Enrolled
Florida State UniversityLead Sponsor
197 Previous Clinical Trials
30,481 Total Patients Enrolled
University of California, San FranciscoOTHER
2,496 Previous Clinical Trials
11,933,682 Total Patients Enrolled

Media Library

Adapted Brothers Saving Brothers (aBSB) Clinical Trial Eligibility Overview. Trial Name: NCT03680729 — N/A
HIV/AIDS Research Study Groups: aBSB, Street Outreach
HIV/AIDS Clinical Trial 2023: Adapted Brothers Saving Brothers (aBSB) Highlights & Side Effects. Trial Name: NCT03680729 — N/A
Adapted Brothers Saving Brothers (aBSB) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03680729 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are enrollees being accepted at the present time into this clinical investigation?

"As conveyed on clinicaltrials.gov, this research study is currently recruiting participants. The trial was first released to the public on February 24th 2020 and recently updated in August 18th 2022."

Answered by AI

What is the current number of participants that have enrolled in this experimental research?

"Indeed, clinicaltrials.gov states that this trial is actively seeking individuals to participate and was first uploaded in February of 2020. It has since been updated on August 18th 2022, with 167 people required at a single site."

Answered by AI

Is there an upper age restriction for qualification in this research study?

"This study's criteria for participant eligibility necessitates that they are between 18 and 99 years old. There are 113 studies allocated to those younger than 18, while 378 trials have been designed with individuals older than 65 in mind."

Answered by AI

Is it feasible to become a participant in this clinical experiment?

"This clinical trial is currently enrolling 167 individuals who suffer from acquired immunodeficiency syndrome and are aged between 18-99. Prospective participants must demonstrate that they meet the following requirements: A minimum age of 18 years, self-identify as black or African American, routinely interact with youth, engage in community outreach and HIV testing initiatives, be able to read English text fluently, provide informed consent willingly, be biologically male and sexually active with other males (MSM)."

Answered by AI
~3 spots leftby Apr 2024